These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9890328)

  • 1. The role of government in health insurance markets with adverse selection.
    Feldman R; Escribano C; Pellisé L
    Health Econ; 1998 Dec; 7(8):659-70. PubMed ID: 9890328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Private purchasing pools to harness individual tax credits for consumers.
    Curtis RE; Neuschler E; Forland R
    Inquiry; 2001; 38(2):159-76. PubMed ID: 11529513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markets for individual health insurance: can we make them work with incentives to purchase insurance?
    Swartz K
    Inquiry; 2001; 38(2):133-45. PubMed ID: 11529511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse selection and regulation in health insurance markets.
    Neudeck W; Podczeck K
    J Health Econ; 1996 Aug; 15(4):387-408. PubMed ID: 10164036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk segmentation: goal or problem?
    Feldman R; Dowd B
    J Health Econ; 2000 Jul; 19(4):499-512. PubMed ID: 11010237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of partial public insurance programs and residual private insurance markets: evidence from the US Medicare program.
    Finkelstein A
    J Health Econ; 2004 Jan; 23(1):1-24. PubMed ID: 15154686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection in insurance markets: theory and empirics in pictures.
    Einav L; Finkelstein A
    J Econ Perspect; 2011; 25(1):115-38. PubMed ID: 21595322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing health care market reform through an insurance exchange: essential policy components, the public plan option, and other issues to consider.
    Fronstin P; Ross MN
    EBRI Issue Brief; 2009 Jun; (330):1-22. PubMed ID: 19545086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Options and opportunities for individuals and families in the private health insurance market.
    Trautwein JS
    Health Aff (Millwood); 2002; Suppl Web Exclusives():W387-90. PubMed ID: 12703599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative health insurance schemes: a welfare comparison.
    Hansen BO; Keiding H
    J Health Econ; 2002 Sep; 21(5):739-56. PubMed ID: 12349880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health Care Sharing Ministries: What Are the Risks to Consumers and Insurance Markets?
    Volk J; Curran E; Giovannelli J
    Issue Brief (Commonw Fund); 2018 Aug; 2018():1-12. PubMed ID: 30091863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supplemental health insurance: did Croatia miss an opportunity?
    Langenbrunner JC
    Croat Med J; 2002 Aug; 43(4):403-7. PubMed ID: 12187517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comment on Neudeck and Podczeck's "adverse selection and regulation in health insurance markets".
    Encinosa W
    J Health Econ; 2001 Jul; 20(4):667-73. PubMed ID: 11463193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual insurance: health insurers try to tap potential market growth.
    November EA; Cohen GR; Ginsburg PB; Quinn BC
    Res Brief; 2009 Nov; (14):1-8. PubMed ID: 19899193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive markets for individual health insurance.
    Harrington S; Miller T
    Health Aff (Millwood); 2002; Suppl Web Exclusives():W359-62. PubMed ID: 12703592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inside the sausage factory: improving estimates of the effects of health insurance expansion proposals.
    Glied S; Remler DK; Zivin JG
    Milbank Q; 2002; 80(4):603-35, iii. PubMed ID: 12532642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse selection and the challenges to stand-alone prescription drug insurance.
    Pauly MV; Zeng Y
    Front Health Policy Res; 2004; 7():55-74. PubMed ID: 15612335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health insurance: the collective purchase of individual care.
    Evans RG
    Health Policy; 1987 Apr; 7(2):115-34. PubMed ID: 10312072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumer information surplus and adverse selection in competitive health insurance markets: an empirical study.
    van de Ven WP; van Vliet RC
    J Health Econ; 1995 Jun; 14(2):149-69. PubMed ID: 10154655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential premium range of risk-rating in competitive markets for supplementary health insurance.
    Paolucci F; Prinsze F; Stam PJ; van de Ven WP
    Int J Health Care Finance Econ; 2009 Sep; 9(3):243-58. PubMed ID: 19125326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.